Fundraising Fox

Accolade

Plymouth Meeting, US · Founded 2010 · Delaware corporation · 14 known investors

Accolade provides virtual healthcare services including primary care, mental health therapy, and benefits navigation for employees and their families. The platform connects members with doctors, therapists, and care advocates to simplify healthcare access and decision-making.

Also known as Accolade, Inc.

Founders & leadership

Accolade was founded in 2010 by Thomas K Spann.

TK
Thomas K SpannFounder
SB
Steve BarnesExecutive
RS
Rajeev SinghChief Executive Officer
DC
Debbie CohenExecutive
JR
John RollinsExecutive
JS
Jeff SmithExecutive
JC
James C. Madden, VNamed on SEC filing

Board

MT
Michael T. YangBoard director
JM
J. Michael ClineBoard directorFounding Partner at Accretive, LLC
WF
William Frist, Sr.Board director
EJ
Edgar, Jr. BronfmanBoard director
WF
William FristBoard director

Investors · 14

Reported raises · per SEC filings

Form D private placements

$610.1M disclosed across 8 rounds · 2014–2021

$11.3MraisedOct 2021 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Patricia WadorsDirector
  • Elizabeth NabelDirector
  • Cindy KentDirector
  • Peter KleinDirector
  • Jeff JordanDirector
  • Robert CavanaughExecutive Officer
  • Michael HiltonExecutive Officer
  • Rajeev SinghExecutive Officer, Director
  • Jeffrey BrodskyDirector
  • Stephen BarnesExecutive Officer
  • Thomas J. NeffDirector
  • Dawn LeporeDirector
Offering amount
$12.5M
Amount sold
$11.3M
First sale
Sep 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$325.3MraisedJun 2021 · 79 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Cindy KentDirector
  • Rajeev SinghExecutive Officer, Director
  • Jeff BrodskyDirector
  • Stephen BarnesExecutive Officer
  • Jeff JordanDirector
  • Dawn LeporeDirector
  • Robert CavanaughExecutive Officer
  • Elizabeth NabelDirector
  • Michael HiltonExecutive Officer
  • Thomas J. NeffDirector
  • Peter KleinDirector
  • Patricia WadorsDirector
Offering amount
$390.4M
Amount sold
$325.3M
First sale
Jun 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$130MraisedMar 2021 · 43 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Thomas J. NeffDirector
  • Cindy KentDirector
  • J. Michael ClineDirector
  • Peter KleinDirector
  • Patricia WadorsDirector
  • William Frist, Sr.Director
  • Dawn LeporeDirector
  • Stephen BarnesExecutive Officer
  • Jeff JordanDirector
  • Robert CavanaughExecutive Officer
  • Michael HiltonExecutive Officer
  • Rajeev SinghExecutive Officer, Director
Offering amount
$230M
Amount sold
$130M
First sale
Mar 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$20MraisedOct 2019 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Edgar Bronfman, Jr.Director
  • James C. Madden, VDirector
  • J. Michael ClineDirector
  • Peter KleinDirector
  • Michael T. YangDirector
  • Thomas J. NeffDirector
  • Dawn LeporeDirector
  • Stephen BarnesExecutive Officer
  • Jeff JordanDirector
  • Rajeev SinghExecutive Officer, Director
  • Mike HiltonExecutive Officer
  • William Frist, Sr.Director
  • Richard EskewExecutive Officer
  • Robert CavanaughExecutive Officer
Offering amount
$20M
Amount sold
$20M
First sale
Oct 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$27.2MraisedMar 2018 · 17 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael T. YangDirector
  • J. Michael ClineDirector
  • Edgar Bronfman, Jr.Director
  • Robert CavanaughExecutive Officer
  • Jeff JordanDirector
  • Thomas K SpannExecutive Officer, Director
  • James C. Madden, VDirector
  • Ivor HornExecutive Officer
  • Mark MactasDirector
  • Stephen BarnesExecutive Officer
  • Dave SwiftExecutive Officer
  • Thomas J. NeffDirector
  • Rajeev SinghExecutive Officer, Director
  • Elizabeth NapolitanoExecutive Officer
  • William Frist, Sr.Director
  • Richard EskewExecutive Officer
  • Mike HiltonExecutive Officer
Offering amount
$50M
Amount sold
$27.2M
First sale
Mar 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$55MraisedAug 2016 · 4 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeff JordanDirector
  • Mark MactasDirector
  • Sheila BurkeDirector
  • James C. Madden, VDirector
  • Michael T. YangDirector
  • Thomas K SpannExecutive Officer, Director
  • Stephen BarnesExecutive Officer
  • Thomas J. NeffDirector
  • J. Michael ClineDirector
  • Edgar Bronfman, Jr.Director
  • William Frist, Sr.Director
  • Rajeev SinghExecutive Officer, Director
Offering amount
$60M
Amount sold
$55M
First sale
Jul 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$38.6MraisedDec 2015 · 5 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Sheila BurkeDirector
  • Michael T. YangDirector
  • Steve BarnesExecutive Officer
  • Thomas J. NeffDirector
  • J. Michael ClineDirector
  • John W. RoweDirector
  • James C. Madden, VDirector
  • William Frist, Sr.Director
  • Mark MactasDirector
  • Thomas K SpannExecutive Officer, Director
  • Rajeev SinghExecutive Officer, Director
  • Debbie CohenExecutive Officer
  • Edgar Bronfman, Jr.Director
Offering amount
$53.6M
Amount sold
$38.6M
First sale
Jul 2015
Incorporated
Corporation, Delaware, 2010
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$2.8MraisedMay 2014 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • J. Michael ClineDirector
  • Edgar, Jr. BronfmanDirector
  • Thomas J. NeffDirector
  • John RollinsExecutive Officer
  • John W. RoweDirector
  • Arthur H. SpiegelDirector
  • William FristDirector
  • James C. MaddenDirector
  • Thomas K SpannExecutive Officer, Director
  • Michael T. YangDirector
  • Jeff SmithExecutive Officer
Offering amount
$2.8M
Amount sold
$2.8M
First sale
Apr 2014
Incorporated
Corporation, Delaware, 2010
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Company profile

researched Aug 2026

Accolade provides healthcare and benefits support to individuals and families through employer-sponsored programs. Members access the service via a member portal and mobile app, where they can view health plan coverage, find in-network providers, track claims, store and share insurance ID cards, and message a Care Advocate or nurse. Depending on the benefits their employer has purchased, members may have access to virtual primary care, virtual mental health care, expert medical opinion, or care navigation services.

The service is delivered by a care team that includes advocates, nurses, doctors, therapists, and specialists. Virtual primary care covers urgent and ongoing conditions, mental health, preventive care, and prescriptions, with same- and next-day appointments available by phone, tablet, or computer. Accolade states its physicians trained at top-50 U.S. medical schools and top-tier institutions. Through 2nd.MD by Accolade, members can obtain a virtual second opinion on a diagnosis, treatment plan, or medication from a specialist via phone or video consultation. Accolade also connects members to third-party "Trusted Partner" benefits covering areas such as digital physical therapy, diabetes care, fertility, and behavioral health.

Business model

Accolade's services are made available to members through their employers' benefits programs, with member-facing services such as Care Advocate and nurse guidance and second medical opinions described as available at no additional cost to the member.

Traction

Accolade reports that 90% of members are satisfied with its advocacy service and that 91% of Accolade Care members say it is easy to access a high-quality doctor or hospital. It cites a network of more than 900 specialists reachable within days through 2nd.MD by Accolade.

Full profile — technology, go-to-market

Technology

A member portal and mobile app consolidate benefits access, provider search, plan coverage and claims information, insurance ID card storage, and secure messaging with care team members, alongside virtual (phone and video) clinical consultations.

Go-to-market

Distribution runs through employer benefits programs; members activate an account or log in to the portal or app to begin using the services included in their benefits.

Employees and their family members who receive Accolade as part of an employer benefits package.

Compiled by commissioned research from 1 cited public sources — announcements, filings, and press listed under research sources below.

Key figures

latest reported
Accolade Care members reporting easy access to a high-quality doctor or hospitalJan 202691%
Member satisfaction with Accolade advocacyJan 202690%
Specialists available through 2nd.MD by AccoladeJan 2026900 specialists

Company-reported or press-reported figures, each dated to when it was claimed — not independently audited.

Founder mafia

4 people who came through Accolade went on to found or lead other companies.

Competitors · 1

by search overlap

Companies competing with Accolade for the same Google search keywords, organic and paid, via search-intersection analysis.

Acquisitions · 1

Early investors' stakes continue via these deals
HealthReveal

Identifies gaps in evidence-based care and guides clinicians to appropriate interventions; acquired by Accolade.

Legal entities · 1

corporate structure
AccoladeDelaware

In the news

Research sources · 1

primary sources listed

1 public sources were cited for this profile; the first-party ones are listed here.

Frequently asked questions

What does Accolade do?
Accolade offers employer-sponsored healthcare navigation with virtual primary care, mental health, and expert medical opinion services.
Who founded Accolade?
Accolade was founded by Thomas K Spann in 2010.
Who are Accolade's investors?
Accolade's investors include 7wire Ventures, Accretive, LLC, Alumni Ventures, Andreessen Horowitz, Basecamp Fund, Blue Ivy Ventures, Carrick Capital Partners, Castor Ventures (an Alumni Ventures Fund) and 6 more.
How much funding has Accolade raised?
Accolade has disclosed $610.1M raised across 8 rounds.
Where is Accolade headquartered?
Accolade is headquartered in Plymouth Meeting, US.